Acasti Pharma Inc EV/Sales
What is the EV/Sales of Acasti Pharma Inc?
The EV/Sales of Acasti Pharma Inc is N/A
What is the definition of EV/Sales?
Enterprise value to sales ratio compares a company’s total value to its sales.
ttm (trailing twelve months)
Enterprise value/sales is a valuation ratio that compares the company's enterprise value to its annual sales. It indicates the company's capacity to generate free cash flow. In general, the lower the ratio, the cheaper the company is.
EV/Sales is most often calculated as cash and cash equivalents subtracted from the sum of market capitalization and debt and divided by annual sales. Many analysts consider EV/sales to be a more accurate metric than Price/Sales as it considers both debt and equity holders in its calculation. One of the limitations of the calculation is that sales do not take into account a company's taxes or expenses.
EV/Sales of companies in the Health Care sector on NASDAQ compared to Acasti Pharma Inc
What does Acasti Pharma Inc do?
acasti pharma, inc., a subsiduary of neptune technologies & bioressources, is a quebec-based biopharmaceutical dedicated in advancing a proprietary portfolio based on marine phospholipids. our products can be used in prescription, medical food and over-the-counter applications, either as a stand-alone, or, as a fixed-dose combination to exisitng productrs, for the prevention and treatment of cardiometabolic disorders.
Companies with ev/sales similar to Acasti Pharma Inc
- Leap Therapeutics Inc has EV/Sales of N/A
- Strike has EV/Sales of N/A
- VYNE Therapeutics has EV/Sales of N/A
- Tissue Repair Ltd has EV/Sales of N/A
- Catheter Precision has EV/Sales of N/A
- Mirasol Resources has EV/Sales of N/A
- Acasti Pharma Inc has EV/Sales of N/A
- Pembroke Venture Capital Trust has EV/Sales of N/A
- Maven Income & Growth VCT has EV/Sales of N/A
- Ayala Pharmaceuticals has EV/Sales of N/A
- Yatra Capital has EV/Sales of N/A
- SREI Infrastructure Finance has EV/Sales of N/A
- Aquarius AI has EV/Sales of N/A